Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00050128 · ClinicalTrials.gov registry record · Phase 1

Preliminary Study of Transcranial Magnetic Stimulation for Stroke Rehabilitation

A Phase 1 study of Cerebrovascular Accident, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

Completed
Registry status
Phase 1
Development phase
15
Enrollment target
1
Study location

NCT00050128: Completed Phase 1 study of Cerebrovascular Accident, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

NCT00050128 is a Phase 1 study of Cerebrovascular Accident that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 15 participants, below the 517-participant average among 26 other Cerebrovascular Accident trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00050128, a Phase 1 study of Cerebrovascular Accident, has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

COMPLETED
Registry status
Phase 1
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

This is a preliminary study to evaluate the possible use of transcranial magnetic stimulation (TMS), together with exercise, for rehabilitation of chronic stroke patients. It will identify the optimum stimulation settings (within the limits of current safety guidelines) to be used in a later rehabilitation study and confirm the safety of the procedure at these settings. Some previous studies using TMS to treat movement disorders such as Parkinson's disease have shown improvement in motor function; others have not. The results of this study may provide information to help researchers design better rehabilitation treatments after stroke. Stroke patients with residual arm function and no history of seizures may be eligible for this study. The stroke must have occurred at least 6 months before entry into the study and must have affected only one side of the brain. For the TMS procedure, subjects are seated in a comfortable chair with their hands placed on a pillow on their lap. An insulated wire coil is placed on the scalp. A brief electrical current is passed through the coil, creating a magnetic pulse that stimulates the outer part of the brain, called the cortex. This may cause muscle, hand or arm twitching if the coil is near the part of the brain that controls movement, or it may affect movements or reflexes. Subjects are asked to make movements, do simple tasks, or tense muscles. Metal electrodes are taped to the skin over the muscle for computer recording of the electrical activity of the hand and arm muscles activated by the stimulation. The testing lasts 2-3 hours.

Conditions Studied

Interventions

  • DEVICE rTMS, Magstim

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2002-11-18
Est. Completion 2007-10-24
Phase Phase 1

What the finished NCT00050128 record still lists

NCT00050128 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 517-participant average among 26 other Cerebrovascular Accident trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Cerebrovascular Accident appearing as the primary indexed condition, and to 1 intervention - of which rTMS, Magstim is the first listed.

NCT00050128 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT00050128 about?

NCT00050128 is a clinical study titled "Preliminary Study of Transcranial Magnetic Stimulation for Stroke Rehabilitation". This is a preliminary study to evaluate the possible use of transcranial magnetic stimulation (TMS), together with exercise, for rehabilitation of chronic stroke patients. It will identify the optimum stimulation settings (within the limits of current safety guidelines) to be used in a later rehabil...

What is the current status of trial NCT00050128?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2002-11-18. Estimated completion is 2007-10-24.

What conditions does trial NCT00050128 study?

This clinical trial studies the following conditions: Cerebrovascular Accident.

What interventions are being tested in trial NCT00050128?

The interventions under investigation include: rTMS, Magstim (DEVICE).

Who is sponsoring clinical trial NCT00050128?

This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00050128 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cerebrovascular Accident

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00050128's enrollment target sits among peer trials

15 27th of 26 the lowest of 26 other Cerebrovascular Accident trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cerebrovascular Accident trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00050128, the US trial registry maintained by the National Library of Medicine. NCT00050128 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.